The Rare Disease Company Coalition (RDCC) represents life science companies committed to discovering, developing, and delivering treatments for rare diseases. The coalition aims to inform policymakers about the unique challenges faced in the development of rare disease therapies and advocate for supportive government policies that facilitate research and access to treatments.